- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06057376
Impact of Two Dietary Interventions on Simple Carbohydrate Intolerance
Clinical Comparison of the Impact of Two Dietary Interventions on Abdominal Pain and Intestinal Microbiome Caused by Simple Carbohydrate Intolerance.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
This is a prospective cross over study. Participants who meet the study entry criterion, will be randomized to a specific dietary intervention: low FODMAP for a 3-week period or Limited Added Sugar for 3 weeks. After the initial study phase, participants will enter a 3 week break followed by a crossover to the other diet phase.
Each participant will be randomized to either the low-FODMAP diet group (LFD) or the low added sugar diet group (LAS) for 3 weeks. All participants will be assigned to a nutrition intervention consisting of 2 one-hour counseling sessions (pre and post diet initiation) plus one 30 min telephone session at week 1 and 2 of the intervention for both diet groups. Macronutrients will not be restricted and both study diets will be ad libitum. Diet interventions will include administration of a 24 hour food recall and completion of the Comprehensive Nutrition Assessment Questionnaire in addition to comprehensive education of the assigned diet.
Investigators will collect stool samples prior to intervention and post each diet intervention to assess initial microbiome composition as well as post intervention changes. Symptom data will be collected via an online survey link consisting of abdominal pain related questionnaires. Measures for child and parent will be requested at the time enrollment of the study and at the end of each diet phase.
Animal studies indicate microbiome adjustment to an increase in dietary carbohydrate pool. It is difficult to capture this change in humans as the microbiome shift may not be evident by actual change in certain strains but by genomic adjustment. Investigators propose a metagenomic approach in combination with metabolomics to identify microbiome end products present as a result of changes in dietary carbohydrate intake by dietary elimination.
Investigators will characterize shifts in metagenomic composition in response to dietary shifts using multivariate methods and linear mixed effects models. To address our hypothesis that FODMAP and low added sugar diets will affect microbial gene content in similar ways, investigators will compare metagenomic shifts relative to a baseline diet using multivariate models that control for subject, age, sex, diet order and potential confounding factors in PerMANOVA and distance-based redundancy analyses. Investigators will have 95% power to detect medium shifts in metabolic profiles among dietary groups (Cohen's D = 0.520). Investigators will use mixed effect linear models to measure enrichment for specific metabolic pathways and diet-driven shifts in specific metabolites over time while controlling for subject, age, sex, diet order, symptoms and potential confounding factors. In these repeated measures design, we will have 95% power to detect a small to medium effect of diet on a given metabolite (Cohen's D = 0.371). The Benhamini-Hochberg procedure will be applied to decrease the false discovery rate when running multiple tests (Yoav et al) It is also of interest to analyze how microbial gene content and metabolic profiles covary. Investigators will apply qualitative genetic methods of covariance matrix estimation to determine how metabolite profiles can be predicted by metagenomic content.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Anna Hunter, MD
- Phone Number: (503) 494-1098
- Email: huntean@ohsu.edu
Study Contact Backup
- Name: Deepannita Roy, MPH
- Phone Number: 503-494-8344
- Email: royde@ohsu.edu
Study Locations
-
-
Oregon
-
Springfield, Oregon, United States, 97477
- Recruiting
- Oregon Health and Science University
-
Contact:
- Anna Hunter, MD
- Phone Number: 503-494-1098
- Email: huntean@ohsu.edu
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Age: 5- 18-year-old
- BMI: within normal range for age
- Positive fructose breath test performed as part of diagnostic work up for abdominal pain
- Willingness to consume low FODMAP and Limited Added sugar diet trial and collect required samples
Exclusion Criteria:
- Age: not within range
- BMI: not within range
- Negative fructose breath test
- Any known or suspected intestinal disorder including but not limited to IBD, IBS, celiac disease, Crohn's Disease, food sensitivities, food allergies, significant by-choice food restrictions
- Hormonal disorders
- Use of chronic medications including contraceptives (both oral and subcutaneous), non-hormone secreting IUD- accepted
- Use of oral or IV antibiotics in the last three months
- Daily probiotic use (pill form)
- Daily multi-vitamin except vitamin D supplements
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Other: Low FODMAP group
Participants randomized to this group will be instructed based on published low-FODMAP diet guidelines and provided with sample meal plans to aid in compliance.
Each participant will be randomized to low-FODMAP diet group (LFD) for 3 weeks.
|
Each participant will be following a low-FODMAP diet group for 3 weeks, followed by 3 week break prior to second diet intervention.
|
Other: Low Added Sugar group
Each participant will be randomized to either the low-FODMAP diet group (LFD) or the low added sugar diet group (LAS) for 3 weeks.
Each participant will be randomized to the low added sugar diet group (LAS) for 3 weeks.
|
Each participant will be following a low added sugar diet group for 3 weeks, after 3 week break.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Abdominal Pain
Time Frame: 63 days
|
Diet impact on abdominal pain as assessed by a questionnaire before and after each diet intervention
|
63 days
|
Effect of each diet on microbiome and metabolome
Time Frame: 63 days
|
Impact of each diet intervention on microbiome and metabolome will be assessed utilizing a stool sample collected prior to and after diet completion
|
63 days
|
Collaborators and Investigators
Investigators
- Principal Investigator: Anna Hunter, MD, Oregon Health and Science University
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- IRB No.24928
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Carbohydrate Intolerance
-
Glycemic Index Laboratories, IncAgriculture and Agri-Food CanadaCompletedCarbohydrate Intolerance
-
University of TorontoGlycemic Index Laboratories, IncCompletedCarbohydrate IntoleranceCanada
-
Ausnutria Hyproca B.V.HM hospitalesCompleted
-
Augusta UniversityTerminatedDietary Fructose IntoleranceUnited States
-
University of LausanneUniversity of LiegeCompletedHereditary Fructose IntoleranceBelgium
-
Maastricht University Medical CenterPfizerCompleted
-
University of LausanneCompletedGlucose Metabolism Disorders | Fructose Metabolism, Inborn Errors | Hereditary Fructose Intolerance
-
Texas A&M UniversityCurves InternationalCompletedCarbohydrate Intolerance
-
University of ReadingCompletedMilk IntoleranceUnited Kingdom
-
Purdue UniversityCompletedLactose Intolerance, Adult TypeUnited States
Clinical Trials on Low-FODMAP diet group (LFD)
-
Ashok TutejaUnited States Department of DefenseUnknown
-
Duke UniversityRobert C. Atkins FoundationCompleted
-
Cantonal Hospital of St. GallenCompletedIBS - Irritable Bowel Syndrome
-
Beth Israel Deaconess Medical CenterEnrolling by invitation
-
Ohio State UniversityCompletedAutism Spectrum DisorderUnited States
-
University of NottinghamKing's College LondonCompletedIrritable Bowel SyndromeUnited Kingdom
-
Northwestern UniversityWithdrawn
-
Taipei Veterans General Hospital, TaiwanNot yet recruitingIrritable Bowel Syndrome
-
Universitaire Ziekenhuizen KU LeuvenCompletedFunctional Dyspepsia | FODMAP DietBelgium
-
Oslo University HospitalActive, not recruitingIrritable Bowel Syndrome | Diet Modification | Celiac Disease | Gluten SensitivityNorway